Schizophrenia risk genes: Implications for future drug development and discovery.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemical Pharmacology

• Publication date

  2011-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bcp.2010.11.009PMID 21093417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia

  2011cited by this paper
• Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder

  2011cited by this paper
• Copy number variation of the SELENBP1 gene in schizophrenia

  2010cited by this paper
• The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors

  2010cited by this paper
• Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia.

  2010cited by this paper
• Targeting the correct HDAC(s) to treat cognitive disorders.

  2010cited by this paper
• Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis

  2010cited by this paper
• Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review.

  2010cited by this paper
• Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders

  2010cited by this paper
• Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

  2010cited by this paper
• Animal models of neuropsychiatric disorders

  2010cited by this paper
• The psychosis susceptibility gene ZNF804A: associations, functions, and phenotypes.

  2010cited by this paper
• From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia

  2009cited by this paper
• Novel Environment and GABA Agonists Alter Event-Related Potentials in N-Methyl-d-aspartate NR1 Hypomorphic and Wild-Type Mice

  2009cited by this paper
• Clinical phenotypes associated with DISC1, a candidate gene for schizophrenia

  2009cited by this paper
• Epigenetic regulation in human brain-focus on histone lysine methylation.

  2009cited by this paper
• Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring

  2009cited by this paper
• Modeling cognitive endophenotypes of schizophrenia in mice.

  2009cited by this paper
• Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses.

  2009cited by this paper
• Further evidence for an association of G72/G30 with schizophrenia in Chinese.

  2009cited by this paper
• Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.

  2009cited by this paper
• Disruptive insights in psychiatry: transforming a clinical discipline.

  2009cited by this paper
• Associative learning and the genetics of schizophrenia.

  2009cited by this paper
• Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept

  2009cited by this paper
• The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants

  2009cited by this paper
• Dissecting the phenotype in genome-wide association studies of psychiatric illness

  2009cited by this paper
• Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.

  2009cited by this paper
• Neurexin 1 (NRXN1) deletions in schizophrenia.

  2009cited by this paper
• Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.

  2009cited by this paper
• Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.

  2009cited by this paper
• Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study.

  2009cited by this paper
• The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: Replication in schizophrenia and extension to bipolar disorder with psychosis

  2008cited by this paper
• Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

  2008cited by this paper
• What CATIE did: some thoughts on implications deep and wide.

  2008cited by this paper
• Identification of loci associated with schizophrenia by genome-wide association and follow-up

  2008cited by this paper
• Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia

  2008cited by this paper
• The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine

  2008cited by this paper
• In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

  2008cited by this paper
• Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes.

  2008cited by this paper
• Special Section on Implications of CATIE: What CATIE Did: Some Thoughts on Implications Deep and Wide

  2008cited by this paper
• Synthesis and biological evaluation of D-amino acid oxidase inhibitors.

  2008cited by this paper
• The effects of a neuregulin 1 variant on white matter density and integrity

  2008cited by this paper
• Enlargement of the lateral ventricles in mutant DISC1 transgenic mice

  2008cited by this paper
• Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new.

  2008cited by this paper
• Large recurrent microdeletions associated with schizophrenia

  2008cited by this paper
• Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia.

  2008cited by this paper
• How has DISC1 enabled drug discovery?

  2008cited by this paper
• Rare chromosomal deletions and duplications increase risk of schizophrenia

  2008cited by this paper
• Integrated detection and population-genetic analysis of SNPs and copy number variation

  2008cited by this paper
• Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia

  2007cited by this paper
• Behavioral phenotypes of Disc1 missense mutations in mice.

  2007cited by this paper
• Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene Promoters

  2007cited by this paper
• Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain.

  2007cited by this paper
• Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Evidence for association and epistasis at the DAOA/G30 and D‐amino acid oxidase loci in an Irish schizophrenia sample

  2007cited by this paper
• Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters

  2007cited by this paper
• Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

  2007cited by this paper
• Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection

  2007cited by this paper
• Schizophrenia drug says goodbye to dopamine

  2007cited by this paper
• Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness

  2007cited by this paper
• The peripheral-blood transcriptome: new insights into disease and risk assessment.

  2007cited by this paper
• Mapping autism risk loci using genetic linkage and chromosomal rearrangements

  2007cited by this paper
• The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases

  2006cited by this paper
• A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms

  2006cited by this paper
• Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.

  2006cited by this paper
• Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation.

  2006cited by this paper
• Impact Assessment of Neuroimaging

  2006cited by this paper
• DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1.

  2006cited by this paper
• Cellular basis of reduced cortical reelin expression in schizophrenia.

  2006cited by this paper
• Gene Expression Profiling in Schizophrenia and Related Mental Disorders

  2006cited by this paper
• Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia

  2005cited by this paper
• Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology.

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.

  2005cited by this paper
• Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.

  2005cited by this paper
• Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.

  2005cited by this paper
• The G72/G30 gene locus in psychiatric disorders: a challenge to diagnostic boundaries?

  2005cited by this paper
• Developing drugs for cognitive impairment in schizophrenia.

  2005cited by this paper
• Reelin Modulates NMDA Receptor Activity in Cortical Neurons

  2005cited by this paper
• GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families

  2005cited by this paper
• DNA methylation and human disease

  2005cited by this paper
• DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

  2005cited by this paper
• The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

  2004cited by this paper
• The GABA-glutamate connection in schizophrenia: which is the proximate cause?

  2004cited by this paper
• Amisulpride augmentation of clozapine: an open non‐randomized study in patients with schizophrenia partially responsive to clozapine

  2004cited by this paper
• DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy.

  2004cited by this paper
• GABA and Schizophrenia: A Review of Basic Science and Clinical Studies

  2003cited by this paper
• Association Analysis of the Genetic Variants of the N-Methyl D-Aspartate Receptor Subunit 2b (NR2b) and Treatment-Refractory Schizophrenia in the Chinese

  2003cited by this paper
• DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains

  2003cited by this paper
• Selenium deficiency increases susceptibility to glutamate‐induced excitotoxicity

  2003cited by this paper
• Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.

  2002cited by this paper
• Applications of microarrays in the pharmaceutical industry.

  2002cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics.

  2002cited by this paper
• Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia

  2002cited by this paper
• Applications of microarrays in the pharmaceutical industry.

  2002cited by this paper
• An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability

  2002cited by this paper

• Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia

  2022cites this paper
• Şizofrenide Epigenetik Bakış Açısı: DNA Metilasyon Modelleri

  2022cites this paper
• Schizophrenia Aetiology and Drug Therapy: A Tale of Progressive Demystification and Strides in Management

  2018cites this paper
• Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features

  2017cites this paper
• Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples

  2017cites this paper
• Recent genetic findings in schizophrenia and their therapeutic relevance

  2015cites this paper
• Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls.

  2015cites this paper
• A molecular pathway analysis informs the genetic background at risk for schizophrenia.

  2015cites this paper
• Expression and neural correlates of schizophrenia risk gene ZNF804A

  2013cites this paper
• The implications of genomics on the nursing care of adults with neuropsychiatric conditions.

  2013cites this paper
• Cholecystokinin A Receptor (CCKAR) Gene Variation Is Associated with Language Lateralization

  2013cites this paper
• Behavioral animal models of antipsychotic drug actions.

  2012cites this paper
• Genetic mouse models relevant to schizophrenia: taking stock and looking forward.

  2012cites this paper
• The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease

  2012cites this paper
• Pharmacological Treatments in Schizophrenia

  2012cites this paper
• Diffusion tensor imaging data reveals GRM3 polymorphism's association with white matter integrity in schizophrenia

  2011cites this paper